毒物和解毒人睡一张床The Poisoned Sleep With the Poisoners
1974年,一位德国胃肠病学家在纽约德尔莫尼科酒店向塑料与石化企业高管展示:动物吞下的塑料微粒能穿过肠壁,进入血液、淋巴,再抵达大脑和肝脏。联合碳化物公司的一位高管把这称作“关于摄入 PVC 树脂的恐怖故事”。五十年后,微塑料出现在人类的血液、大脑、胎盘和睾丸里。当年那场演示没有让任何人停下,它只是让企业学会了怎么说。
这就是第三章讲的东西:认知入口的争夺,从来不是“有没有证据”,而是“谁来解释证据、谁有权把证据变成规则”。企业赞助研究、追踪风险、发现低剂量暴露的动物长肿瘤、吸入氯乙烯的工人反复得同一种罕见癌症,然后继续反对联邦监管。1984年大陆石油化工的一位高管说:“我们活在一片致癌物的海洋里,我们不仅活着,还活得更久了。”这句话的语法值得记住:把受害说成适应,把适应说成胜利。
五十年后,这套语法换了个说话人。MAHA 的群众真的在担心微塑料,担心得有道理。但共和党把污染者请进政府,2025年6月环保署拒绝把微塑料列入饮用水监测优先清单;肯尼迪的卫生与公众服务部拿出1.44亿美元搞“微塑料研究项目”,白宫的 MAHA 报告说微塑料可能让孩子生病,环保署同意“研究”。全是研究,没有一条限制。研究是 structural violence 的 PR 版本:它让问题看起来正在被处理,同时把处理无限期推后。
钱的部分更直白。据《纽约时报》调查,特朗普第二任期一开始,工业污染者就申请豁免拜登时代的污染限值;环保署为“受监管群体”设了电子邮箱,2025年3月31日前正式申请。3月19日,美国燃料与石化制造商协会和美国化学理事会的政治行动委员会向共和党候选人和共和党相关 PAC 捐了13笔共5万美元,同一天给民主党3笔共1万美元。月底,两家协会致信环保署,要求两年豁免,不必遵守限制环氧乙烷等毒素的空气质量规则,环氧乙烷是塑料的“关键构件”,也是致癌物。7月,在更多会议和更多捐款之后,它们拿到了想要的东西。
10比5万。这不是隐喻,这是定价。共谋者理论在这里不需要复杂化:出钱的一方、收钱的一方、负责把收钱写成“减少监管负担”的一方,各自的回报清清楚楚。Zen Honeycutt 在爱荷华州的集会上和肯尼迪交谈、和 Calley Means 合影,她的组织对饮用水里的微塑料表达“深切担忧”,然后继续为这个党站台。她不是被骗,她是在一个她算过账的联盟里选了短期最优解:靠近权力,换取一点注意力。代价是她的担忧永远不会变成规则。
MAHA 峰会的赞助商名单把这场运动卖的是什么写在了脸上:沃尔玛,以及靠向焦虑的中年千禧一代推销 GLP-1、抗抑郁药和非那雄胺的 Hims & Hers。一个反建制健康运动,金主是卖药的,站台的是卖保健品的,主办方是肯尼迪的长期出版人。传统基金会的 Jennifer Galardi 警告他们要远离布莱恩·约翰逊那种“反乌托邦宗教”,说自由不是“移除一切限制”,而是“拥抱挣扎、痛苦,甚至死亡”。一个几十年来带头让企业接管政府的机构,现在来劝人接受痛苦。痛苦从来不是平均分配的。
这篇文章最后落到一个真诚的困惑上:为什么有据可查的事实这么难变成问责?答案不在事实这一侧。事实早就齐了,1974年就齐了。难的是解释权在谁手里。当“监管”被写成“自由”的反面,当“研究”被当成“行动”,当一场健康运动的金主就是让它不健康的那批公司,事实就只能在文章里循环,进不了法条。
近九成美国人担心人体里有微塑料,63%“非常担心”。这个数字是现成的政治资本,没人去兑现。兑现它需要的不是又一份报告,而是有人愿意把“这东西让我们生病,得停下来”说成一句可以投票的话,并且得罪出钱的人。谁的名字在这篇报道里始终没出现?那些在1974年酒店里听完演示、然后决定继续生产的人,他们的公司今天还在捐款,他们的名字一个都没被追责。
In 1974, a German gastroenterologist stood in New York's Hotel Delmonico and showed plastics and petrochemical executives that microscopic plastic particles swallowed by animals crossed the intestinal lining into blood and lymph, then reached the brain and liver. A Union Carbide executive called the presentation a "horror story" on ingesting PVC resin. Fifty years later, microplastics turn up in human blood, brains, placentas and testicles. The 1974 briefing didn't stop anyone. It taught the industry how to talk.
This is Chapter 3 in the wild: the fight over the cognitive entrance was never about whether evidence exists, but about who gets to interpret it and who gets to turn interpretation into rules. Companies sponsored and tracked studies, found tumors in animals exposed at low levels, watched workers who inhaled vinyl chloride develop the same rare cancer, and kept fighting federal regulation. A Conoco Chemical executive said in 1984: "We live in a sea of carcinogens and not only are we surviving—we are living longer!" Note the grammar: harm recast as adaptation, adaptation recast as victory.
Fifty years on, the grammar has a new speaker. MAHA's rank and file genuinely worry about microplastics, and they are right to. But the GOP has seated the polluters in government: in June the EPA declined to add microplastics to its drinking-water monitoring priority list; Kennedy's HHS launched a $144 million "microplastics research program"; the White House's MAHA report said microplastics might be making kids sick; the EPA agreed to study them. All study, no limits. Research is the PR edition of structural violence—it makes a problem look handled while postponing the handling indefinitely.
The money is blunter. Per a New York Times investigation, industrial polluters began requesting exemptions from Biden-era limits almost as soon as Trump's second term began; the EPA set up an electronic mailbox for the "regulated community" to formally request exemptions by March 31, 2025. On March 19, the political action committees of the American Fuel and Petrochemical Manufacturers Association and the American Chemistry Council made 13 donations totaling $50,000 to Republican candidates and Republican-aligned PACs, and three totaling $10,000 to Democrats. At month's end the two associations asked the EPA for a two-year exemption from air quality rules limiting ethylene oxide—a "critical building block" for plastics and a carcinogen. In July, after more meetings and many more donations, they got it.
Ten thousand against fifty thousand. That isn't a metaphor, it's a price list. The co-conspirators need no elaborate theory here: the payers, the paid, and the people who write the payment up as "regulatory relief" each know their return. Zen Honeycutt chats with Kennedy at an Iowa rally and poses with Calley Means while her group expresses "deep concern about the growing threat of microplastic pollution to drinking water." She isn't fooled. She has calculated that proximity to power is worth more than the concern she keeps voicing. The price is that the concern never becomes a rule.
The MAHA Summit sponsor list says what the movement is selling: Wal-Mart, and Hims & Hers, best known for marketing GLP-1s, antidepressants and finasteride to insecure, aging millennials. An anti-establishment health movement bankrolled by pill sellers, headlined by a longevity guru, organized by Kennedy's longtime publisher. The Heritage Foundation's Jennifer Galardi warned MAHA away from Bryan Johnson's "dystopian religion," arguing that freedom comes not from "removing all limitations" but from "embracing struggle, pain, and even death." An institution that spent decades letting companies run the government now counsels accepting pain. Pain was never distributed evenly.
The article ends on an honest puzzlement: why is it so hard to turn a well-documented arsenal of facts into accountability? The answer isn't on the facts side. The facts have been complete since 1974. What's scarce is interpretive power. When "regulation" is written as the opposite of "freedom," when "study" passes for "action," when a health movement's funders are the companies making it unhealthy, facts circulate in articles and never reach statutes.
Nearly nine in ten Americans worry that microplastics are in their bodies; 63 percent are "very concerned." That is ready-made political capital nobody is cashing. Cashing it takes more than another report—it takes someone willing to say "this is making us sick, make it stop" as a votable sentence and take the donors on. Whose names never appear in this story? The men who sat in that hotel room in 1974, heard the presentation, and kept producing. Their companies are still donating. Not one of them has been held to account.